NYSE:HESM
NYSE:HESMOil and Gas

Is Raymond James' Downgrade and Chevron-tied Board Shift Altering The Investment Case For Hess Midstream (HESM)?

Recently, Raymond James cut its rating on Hess Midstream from Outperform to Market Perform, citing limited near-term growth prospects, while the company also reshaped its board after director Andrew B. Walz resigned to become an executive officer at Chevron. This combination of a cooler analyst view and governance changes tied to Chevron’s influence raises fresh questions about Hess Midstream’s medium-term growth path and independence. Next, we’ll examine how Raymond James’ downgrade,...
NasdaqCM:SKYT
NasdaqCM:SKYTSemiconductor

Why SkyWater Technology (SKYT) Is Up 21.6% After Strong Texas-Fueled Q4 Revenue Outlook

In recent days, SkyWater Technology reported strong performance from its newly acquired Texas operation and guided fourth-quarter revenue to a US$155 million–US$165 million range, ahead of its February earnings release. An important angle for investors is how this Texas facility appears to be contributing meaningfully to near-term revenue visibility and operational scale. We’ll now examine how the stronger-than-expected contribution from the Texas acquisition could influence SkyWater...
NYSE:SHW
NYSE:SHWChemicals

Assessing Sherwin-Williams (SHW) Valuation As Pricing Power And Cost Discipline Meet Key Earnings Test

Recent analyst commentary around Sherwin-Williams (SHW) has highlighted the company’s pricing power, brand strength, and cost discipline, with investors now looking to the upcoming earnings release as a key test of those themes. See our latest analysis for Sherwin-Williams. At a share price of $327.84, Sherwin-Williams has seen short term share price returns move slightly in both directions recently, while its 3 year total shareholder return of 42.72% contrasts with a slightly negative 1 year...
NYSE:MIR
NYSE:MIRElectronic

A Look At Mirion Technologies (MIR) Valuation After Its Earnings Beat And Nuclear Power Segment Strength

Mirion Technologies (MIR) has drawn fresh attention after reporting quarterly earnings per share ahead of expectations, along with strong performance in its nuclear power end market, yet the stock has retreated following the announcement. See our latest analysis for Mirion Technologies. The latest earnings news arrives after a mixed stretch in the share price, with a 3.03% 90 day share price return and a 36.25% 1 year total shareholder return suggesting long term momentum, while shorter term...
NYSE:RDN
NYSE:RDNDiversified Financial

A Look At Radian Group (RDN) Valuation As Shares Trade Near Recent Levels

Radian Group (RDN) is back on investors’ radar after recent share price moves. The stock last closed at $35.92, prompting fresh questions about how its mortgage and real estate services business is currently valued. See our latest analysis for Radian Group. While the latest move to $35.92 comes with a modest 1-day share price return of 0.19% decline and a 7-day share price return of 0.99% decline, the share price return over the last 30 and 90 days has been positive. Over the longer term,...
NasdaqGS:MLYS
NasdaqGS:MLYSBiotechs

Is JAMA-Lauded Launch-HTN And FDA Feedback Altering The Investment Case For Mineralys Therapeutics (MLYS)?

Mineralys Therapeutics recently advanced its aldosterone synthase inhibitor program as the Phase 3 Launch-HTN trial of Lorundrostat, which showed significant reductions in systolic blood pressure in treatment-resistant hypertension, was recognized in JAMA’s inaugural “Research of the Year,” and the company received FDA pre-NDA feedback supporting a planned New Drug Application submission. This recognition, combined with the prospect of additional Lorundrostat trial readouts expected in 2026,...
NasdaqCM:DCTH
NasdaqCM:DCTHMedical Equipment

Will New HEPZATO KIT Subgroup Data on Tumor Burden and Survival Change Delcath Systems' (DCTH) Narrative

Delcath Systems recently reported publication of subgroup analyses from its phase 3 FOCUS study of the HEPZATO KIT for unresectable metastatic uveal melanoma in the Journal of Cancer Research and Clinical Oncology, detailing efficacy and safety outcomes across multiple patient categories. The data highlight that patients with lower tumor burden and low or normal LDH experienced meaningfully longer progression-free and overall survival, with many responses emerging only after several...
NYSE:APO
NYSE:APODiversified Financial

Assessing Apollo Global Management’s (APO) Valuation After Mixed Recent Returns And Undervalued Fair Value Estimate

Apollo Global Management (APO) is back in focus after recent trading, with the share price last closing at $146.61. For investors, the key questions now center on returns, earnings trends, and valuation. See our latest analysis for Apollo Global Management. Recent trading has been choppy, with a 1-day share price return of 1.28% and a 30-day share price return of 6.14%. However, the 1-year total shareholder return shows a decline of 12.08%, which contrasts with a very large 3-year total...
NasdaqGM:FCEL
NasdaqGM:FCELElectrical

Assessing FuelCell Energy (FCEL) Valuation After Expanded US$200 Million Stock Sale Plan And Volatile Trading

FuelCell Energy (FCEL) is back in focus after the company amended its open market sales agreement to allow up to US$200 million of additional common stock issuance, a move that has coincided with sharp share price swings. See our latest analysis for FuelCell Energy. The amended share sale plan comes after a sharp share price move, with an 11.76% 1 day share price return at the latest close of US$8.17. However, that sits against a 30 day share price return of 2.39% and a 90 day share price...
NYSE:MOH
NYSE:MOHHealthcare

Is Molina Healthcare (MOH) Pricing Reflect Its Value After A 40% One Year Share Price Fall

Are you wondering whether Molina Healthcare's share price reflects its true worth, or if the recent swings have opened up an opportunity for you? The stock last closed at US$178.46, with returns of 7.2% over 7 days and 17.5% over 30 days. Over 1 year the return stands at a 40.2% decline, and the 3 year and 5 year returns show 39.8% and 26.2% declines respectively. These moves sit against an ongoing backdrop of attention on managed care providers. Investors keep a close eye on factors such as...
NasdaqGS:FRMI
NasdaqGS:FRMISpecialized REITs

Assessing Fermi (FRMI) Valuation After Recent Share Price Rebound And DCF Implied Upside

Fermi’s recent price swings and context for investors Fermi (FRMI) has caught investor attention after a sharp near term rebound, with the stock up 10.25% over the past day and 17.29% over the past week, despite weaker recent month and past 3 months returns. See our latest analysis for Fermi. While the recent 1-day and 7-day share price returns have been strong, the 30-day and 90-day share price returns are weaker. This points to short term momentum improving after a difficult few months...
NYSE:BK
NYSE:BKCapital Markets

A Look At Bank Of New York Mellon Corporation (BK) Valuation After Recent Share Price Momentum

Without a clear single event driving headlines, Bank of New York Mellon Corporation (BK) is drawing attention mainly for its recent share performance and fundamentals, prompting investors to reassess how its current valuation aligns with its business profile. See our latest analysis for Bank of New York Mellon. At a latest share price of US$117.04, BNY’s recent 90 day share price return of 9.45% and 1 year total shareholder return of 53.53% point to momentum that has been building rather than...
NYSE:PAGS
NYSE:PAGSDiversified Financial

Is PagSeguro’s One-Off US$0.12 Dividend Reshaping the Capital Return Story for PAGS?

PagSeguro Digital Ltd. has approved a special cash dividend of US$0.12 per common share, payable on February 27, 2026 to shareholders of record on January 28, 2026, subject to market and company financial conditions. This one-off payout highlights how PagSeguro is using excess capital to supplement existing capital return tools such as its share buyback program. We’ll now examine how this special cash dividend decision interacts with PagSeguro’s capital returns-focused investment narrative...
NYSE:ZTS
NYSE:ZTSPharmaceuticals

Is Zoetis (ZTS) Now Priced For Opportunity After Recent Share Price Weakness

This article examines whether Zoetis is now priced for opportunity or still appears expensive after a difficult period, walking through what the numbers indicate about its current value. The share price closed at US$125.92, with a 6.1% gain over the last 30 days and a 23.1% decline over the past year, which may have influenced how the market views its risk and potential. Recent attention on Zoetis has focused on its role in animal health as investors reassess companies linked to long term...
NasdaqGS:COLB
NasdaqGS:COLBBanks

A Look At Columbia Banking System (COLB) Valuation After New Buyback And Increased HoldCo Investment

Columbia Banking System (COLB) is back in focus after authorizing a $700 million share repurchase program and drawing increased interest from institutional investor HoldCo Asset Management, developments that income-focused bank investors are watching closely. See our latest analysis for Columbia Banking System. The share price has been relatively steady at US$28.19, with a 90 day share price return of 7.64% and a 1 year total shareholder return of 8.69%. This suggests momentum is building...
NYSE:NOC
NYSE:NOCAerospace & Defense

Assessing Northrop Grumman (NOC) Valuation As Key Defense Programs Draw Renewed Attention

Why Northrop Grumman is back in focus Northrop Grumman (NOC) is drawing renewed attention as investors weigh its role in high profile Pentagon programs like the B-21 Raider stealth bomber and strategic missile modernization, both central to its long cycle defense revenue base. See our latest analysis for Northrop Grumman. At a share price of $585.66, Northrop Grumman has seen a 6.68% 1 month share price return but a 5.79% decline over 3 months. Its 1 year total shareholder return of 30.91%...
NYSE:DLR
NYSE:DLRSpecialized REITs

Assessing Digital Realty Trust (NYSE:DLR) Valuation After Recent Share Price Weakness

Why Digital Realty Trust Is On Investors’ Radar Digital Realty Trust (NYSE:DLR) has been drawing attention after a period of mixed share performance, with the stock showing a 0.2% move over the past day but a weaker month and past 3 months. For investors watching data center real estate, those recent returns sit alongside a business that reports US$5.8b in revenue and US$1.4b in net income. This has prompted fresh questions about how the market is currently valuing this cash generating...
NYSE:TRV
NYSE:TRVInsurance

Assessing Travelers (TRV) Valuation After Recent Share Price Moves And Long Term Gains

Travelers Companies (TRV) is drawing fresh attention after recent share price moves, with a 1 day return of 1.68% and a 7 day decline of 2.31% prompting closer inspection from investors. See our latest analysis for Travelers Companies. With the share price at US$285.19, a recent 7 day share price return of 2.31% decline contrasts with a stronger 1 year total shareholder return of 19.83%. This suggests that shorter term momentum may be fading while longer term holders have still seen solid...
NasdaqCM:EOSE
NasdaqCM:EOSEElectrical

Assessing Eos Energy Enterprises (EOSE) Valuation After Recent Leadership Change At The Chair Position

Eos Energy Enterprises (EOSE) is back in focus after long serving non executive Chair Russ Stidolph decided to step down, with board member Joseph Nigro set to take over the role. See our latest analysis for Eos Energy Enterprises. The leadership change lands at a time when the latest share price sits at $12.97, with a sharp 13.18% 1 day share price return and 14.27% 7 day share price return standing in contrast to a 13.48% 30 day share price decline. At the same time, the 1 year total...